Revolutionary Therapy for Violent Dreaming in REM Sleep Disorder.
Researchers at Mount Sinai Hospital have identified a new potential treatment for rapid eye movement (REM) sleep behavior disorder, a condition that affects over 3 million Americans and involves acting out dreams during sleep. The study established a new model detailing the disorder’s progression due to neurodegeneration linked with tau protein accumulation. Dual orexin receptor antagonists, used commonly for insomnia, were found to significantly reduce symptoms of this disorder, opening up a promising new treatment option that could potentially have fewer side effects.